Boai NKY Pharmaceuticals Ltd Total Liabilities
Boai NKY Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has total liabilities worth CN¥961.75 Million CNY (≈ $140.73 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Boai NKY Pharmaceuticals Ltd (300109) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Boai NKY Pharmaceuticals Ltd (2007–2025)
Total liabilities of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. This chart illustrates how Boai NKY Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.
Boai NKY Pharmaceuticals Ltd Competitors by Total Liabilities
The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FAWER Automotive Parts Ltd Co
SHE:000030
|
China | CN¥8.81 Billion |
|
Domino's Pizza Enterprises Limited
F:HQX
|
Germany | €2.01 Billion |
|
Olectra Greentech Limited
NSE:OLECTRA
|
India | Rs-12.33 Billion |
|
Dynamatic Technologies Limited
NSE:DYNAMATECH
|
India | Rs9.94 Billion |
|
TOA Paint (Thailand) Public Company Limited
BK:TOA
|
Thailand | ฿6.22 Billion |
|
Cullinan Oncology LLC
NASDAQ:CGEM
|
USA | $36.81 Million |
|
Major Drilling Group International
TO:MDI
|
Canada | CA$231.07 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Boai NKY Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Boai NKY Pharmaceuticals Ltd assets under control.
Liquidity & Leverage Metrics
Boai NKY Pharmaceuticals Ltd Total Liabilities Ratios Explained
Boai NKY Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Boai NKY Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Boai NKY Pharmaceuticals Ltd (2007–2025)
The table below shows the annual total liabilities of Boai NKY Pharmaceuticals Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥713.16 Million ≈ $104.36 Million |
-6.70% |
| 2024-12-31 | CN¥764.37 Million ≈ $111.85 Million |
+52.98% |
| 2023-12-31 | CN¥499.66 Million ≈ $73.12 Million |
-16.20% |
| 2022-12-31 | CN¥596.29 Million ≈ $87.26 Million |
+1.11% |
| 2021-12-31 | CN¥589.76 Million ≈ $86.30 Million |
-44.84% |
| 2020-12-31 | CN¥1.07 Billion ≈ $156.46 Million |
-6.54% |
| 2019-12-31 | CN¥1.14 Billion ≈ $167.42 Million |
+11.42% |
| 2018-12-31 | CN¥1.03 Billion ≈ $150.27 Million |
+56.48% |
| 2017-12-31 | CN¥656.22 Million ≈ $96.03 Million |
+687.58% |
| 2016-12-31 | CN¥83.32 Million ≈ $12.19 Million |
+13.97% |
| 2015-12-31 | CN¥73.11 Million ≈ $10.70 Million |
-1.71% |
| 2014-12-31 | CN¥74.38 Million ≈ $10.88 Million |
+63.18% |
| 2013-12-31 | CN¥45.58 Million ≈ $6.67 Million |
-0.51% |
| 2012-12-31 | CN¥45.81 Million ≈ $6.70 Million |
+18.06% |
| 2011-12-31 | CN¥38.80 Million ≈ $5.68 Million |
+57.75% |
| 2010-12-31 | CN¥24.60 Million ≈ $3.60 Million |
-49.45% |
| 2009-12-31 | CN¥48.66 Million ≈ $7.12 Million |
+2.40% |
| 2008-12-31 | CN¥47.52 Million ≈ $6.95 Million |
-2.70% |
| 2007-12-31 | CN¥48.84 Million ≈ $7.15 Million |
-- |
About Boai NKY Pharmaceuticals Ltd
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precisio… Read more